Patents by Inventor Eric Doris

Eric Doris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9839700
    Abstract: The invention relates to polymerized micelles of size inferior to 100 nm for in vivo diagnosis, in particular of cancer. The polymerized micelles of the invention comprise a diagnostic agent and an amphiphilic polymer obtainable by the polymerization of an amphiphilic monomer, said monomer comprising: a lipophilic chain comprising a polymerizable vinylic or diacetylenic group, and a hydrophilic head comprising a polyoxyethylene or polyoxypropylene chain. The invention finds application in the pharmaceutical field, in particular.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: December 12, 2017
    Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Eric Doris, Frédéric Duconge, Edmond Gravel, Nicolas Mackiewicz, Bertrand Tavitian
  • Patent number: 9791439
    Abstract: A component or device is provided for the detection or the measurement in parallel of one or more specific types of biological or chemical target products. This component includes a group of nanotubes selected and/or functionalized to interact with the target product, around an optical waveguide. Thus, an optical coupling is produced between the optical waveguide and one or more optical characteristics of these nanotubes, the modifications of which are evaluated in the presence of the target product. In addition, a method is provided for manufacturing and preparing such a component or device, and a detection method using them, as well as a post-manufacture preparation method comprising a specific functionalization for different target products starting from the same type of pluripotent generic component. Also provided is a family of PFO-based functionalization polymers.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: October 17, 2017
    Assignees: UNIVERSITE PARIS SUD 11, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Laurent Vivien, Etienne Gaufres, Nicolas Izard, Eric Doris, Edmond Gravel, Didier Boquet
  • Patent number: 8754074
    Abstract: The present invention relates to the use of the vinyl quinuclidine enantiomer (R) of the following formula 2 as a synthesis intermediate in the preparation of (R)-mequitazine.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: June 17, 2014
    Assignees: Pierre Fabre Medicament, Commissariat a l'Energie Atomique et aux Energies Alternatives
    Inventors: Marc Nicolas, Laurent Larquetoux, Sébastien Leroux, Eric Doris
  • Patent number: 8663660
    Abstract: Polymerized micelles comprising polymerized amphiphilic molecules obtained starting from amphiphilic molecules having one or two lipid chains each comprising one or two polymerizable moieties and linked to a polar head.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: March 4, 2014
    Assignees: Les Laboratories Servier, Commissariat a l'Energie Atomique
    Inventors: Julien Ogier, Eric Doris, François Lefoulon, Thomas Arnauld
  • Publication number: 20130316368
    Abstract: A component or device is provided for the detection or the measurement in parallel of one or more specific types of biological or chemical target products. This component includes a group of nanotubes selected and/or functionalized to interact with the target product, around an optical waveguide. Thus, an optical coupling is produced between the optical waveguide and one or more optical characteristics of these nanotubes, the modifications of which are evaluated in the presence of the target product. In addition, a method is provided for manufacturing and preparing such a component or device, and a detection method using them, as well as a post-manufacture preparation method comprising a specific functionalization for different target products starting from the same type of pluripotent generic component. Also provided is a family of PFO-based functionalization polymers.
    Type: Application
    Filed: February 9, 2012
    Publication date: November 28, 2013
    Applicants: UNIVERSITE PARIS SUD 11, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Laurent Vivien, Etienne Gaufres, Nicolas Izard, Eric Doris, Edmond Gravel, Didier Boquet
  • Publication number: 20130296553
    Abstract: The present invention relates to the use of the vinyl quinuclidine enantiomer (R) of the following formula 2 as a synthesis intermediate in the preparation of (R)-mequitazine.
    Type: Application
    Filed: January 10, 2012
    Publication date: November 7, 2013
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, PIERRE FABRE MEDICAMENT
    Inventors: Marc Nicolas, Laurent Larquetoux, Sébastien Leroux, Eric Doris
  • Publication number: 20130230467
    Abstract: The invention relates to polymerized micelles of size inferior to 100 nm for in vivo diagnosis, in particular of cancer. The polymerized micelles of the invention comprise a diagnostic agent and an amphiphilic polymer obtainable by the polymerization of an amphiphilic monomer, said monomer comprising: a lipophilic chain comprising a polymerizable vinylic or diacetylenic group, and a hydrophilic head comprising a polyoxyethylene or polyoxypropylene chain. The invention finds application in the pharmaceutical field, in particular.
    Type: Application
    Filed: July 7, 2011
    Publication date: September 5, 2013
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
    Inventors: Eric Doris, Frédéric Duconge, Edmond Gravel, Nicolas MacKiewicz, Bertrand Tavitian
  • Patent number: 8101748
    Abstract: The fluorinated derivatives of catharanthine according to the invention respond to the general formula I: in which: the dotted line expresses the possibility of the presence of a double bond when the substitution —X is absent or else a single bond when —X designates a substitution for a group: H, OR, NR?R?, SR, or a halogen atom with R, R? and R? designating independently of one another a hydrogen atom or a linear or branched alkyl group in C1 to C6, R1, R2 and R3 represent independently of one another an atom of hydrogen, of fluorine or a methylated group, on the condition nevertheless that at least one of the radicals R1 and R2 represents an atom of fluorine, and n=1 or 2.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: January 24, 2012
    Assignees: Pierre Fabre Medicament, Commissariat a l'Energie Atomique
    Inventors: Lionel Moisan, Sébastien Comesse, Emerson Giovanelli, Bernard Rousseau, Eric Doris, Paul Hellier
  • Publication number: 20110105516
    Abstract: Polymerised micelles comprising polymerised amphiphilic molecules obtained starting from amphiphilic molecules having one or two lipid chains each comprising one or two polymerisable moieties and linked to a polar head.
    Type: Application
    Filed: April 28, 2009
    Publication date: May 5, 2011
    Applicants: LES LABORATOIRES SERVIER, COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Julien Ogier, Eric Doris, Francois Lefoulon, Thomas Arnauld
  • Publication number: 20100093997
    Abstract: The fluorinated derivatives of catharanthine according to the invention respond to the general formula I: in which: the dotted line expresses the possibility of the presence of a double bond when the substitution —X is absent or else a single bond when —X designates a substitution for a group: H, OR, NR?R?, SR, or a halogen atom with R, R? and R? designating independently of one another a hydrogen atom or a linear or branched alkyl group in C1 to C6, R1, R2 and R3 represent independently of one another an atom of hydrogen, of fluorine or a methylated group, on the condition nevertheless that at least one of the radicals R1 and R2 represents an atom of fluorine, and n=1 or 2.
    Type: Application
    Filed: September 20, 2007
    Publication date: April 15, 2010
    Applicants: Pierre Fabre Medicament, COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Lionel Moisan, Sébastien Comesse, Emerson Giovanelli, Bernard Rousseau, Eric Doris, Paul Hellier